Differential cardiovascular responses to blockade of nNOS or iNOS in rostral ventrolateral medulla of the rat
- 1 June 2001
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 133 (4) , 606-614
- https://doi.org/10.1038/sj.bjp.0704105
Abstract
We investigated the contribution of neuronal or inducible nitric oxide synthase (nNOS or iNOS) at the rostral ventrolateral medulla (RVLM) to central cardiovascular regulation by endogenous nitric oxide (NO), using Sprague‐Dawley rats anaesthetized and maintained with propofol. Microinjection bilaterally into the RVLM of a NO trapping agent, carboxy‐2‐phenyl‐4,4,5,5‐tetramethylimidazoline‐l‐oxy‐l‐3‐oxide (10, 50 or 100 nmoles) resulted in significant hypotension and bradycardia. Similar application of a selective antagonist of nNOS, 7‐nitroindazole (1, 2.5 or 5 pmoles), or selective antagonists of iNOS, aminoguanidine (125, 250 or 500 pmoles), N6‐(l‐iminoethyl)‐L‐lysine (250 pmoles) or S‐methylisothiourea (250 pmoles), induced respectively a reduction or an enhancement in systemic arterial pressure, heart rate and power density of the vasomotor components in the spectrum of arterial blood pressure signals, the experimental index for sympathetic neurogenic vasomotor tone. Both hypotension and bradycardia induced by the NO precursor, L‐arginine (100 nmoles), were significantly blunted when aminoguanidine (250 pmoles) was co‐microinjected bilaterally into the RVLM. On the other hand, co‐administered 7‐nitroindazole (2.5 pmoles) was ineffective. Whereas low doses of S‐nitro‐N‐acetylpenicillamine (0.25 or 0.5 nmoles) elicited hypertension and tachycardia, high doses of this non‐nitrate NO donor (5 nmoles) induced hypotension and bradycardia. Reverse transcription – polymerase chain reaction analysis revealed that both iNOS and nNOS mRNA were expressed in the ventrolateral medulla. We conclude that the prevalence of nNOS over iNOS activity at the RVLM and the associated dominance of sympathoexcitation over sympathoinhibition may underlie the maintenance of sympathetic vasomotor outflow and stable systemic arterial pressure by the endogenous NO. British Journal of Pharmacology (2001) 133, 606–614; doi:10.1038/sj.bjp.0704105Keywords
This publication has 56 references indexed in Scilit:
- Formation of guanidinosuccinic acid, a stable nitrix oxide mimic, from argininosuccinic acid and nitric oxide-derived free radicalsFree Radical Research, 1999
- Handy and Moore replyTrends in Pharmacological Sciences, 1998
- Selective inhibitors of neuronal nitric oxide synthase – is no NOS really good NOS for the nervous system?Trends in Pharmacological Sciences, 1997
- Pressor and sympathoexcitatory effects of nitric oxide in the rostral ventrolateral medullaJournal Of Hypertension, 1996
- Cardiovascular Effects of Nitric Oxide in the Brain Stem Nuclei of RatsHypertension, 1996
- Therapeutic Effects of Imidazolineoxyl N-Oxide Against Endotoxin Shock through Its Direct Nitric Oxide-Scavenging ActivityBiochemical and Biophysical Research Communications, 1994
- The subretrofacial vasomotor nucleus: Anatomical, chemical and pharmacological properties and role in cardiovascular regulationProgress in Neurobiology, 1994
- Synthesis of nitric oxide in CNS glial cellsTrends in Neurosciences, 1993
- Purification of a Ca2+/calmodulin‐dependent nitric oxide synthase from porcine cerebellumFEBS Letters, 1990
- Localization of nitric oxide synthase indicating a neural role for nitric oxideNature, 1990